Can miR-34a be used as a biomarker for cancer diagnosis and prognosis?
Yes, miR-34a has the potential to serve as a biomarker for cancer diagnosis and prognosis. Its expression levels can be measured in tissue samples, blood, and other body fluids. Reduced levels of miR-34a are often associated with poor prognosis, increased tumor aggressiveness, and resistance to therapy. Therefore, miR-34a can provide valuable information for cancer detection and monitoring disease progression.
